Amgen: all 1,085 studies
Page 11 of 11. Open to participants first (51), then studies with results posted, then the rest; newest registration first within each.
- Evaluating Efficacy and Safety of Etanercept 50 mg Twice Weekly (BIW) in Rheumatoid Arthritis (RA) Subjects Who Are Sub-Optimal Responders to Etanercept 50 mg Once Weekly (QW)CompletedNCT00115219Phase 4
- Neulasta® in Subjects With Advanced Non-Small-Cell Lung Cancer (NSCLC) During ChemotherapyCompletedNCT00115206Phase 4
- Pegfilgrastim Administered on the Same Day as Chemotherapy in Non-Hodgkin's LymphomaCompletedNCT00115193Phase 2
- A Study of Darbepoetin Alfa in Anemic Subjects Not Receiving Chemotherapy Who Have Completed the 20010103 StudyCompletedNCT00115167Phase 3
- Open-Label Trial of Peripheral Blood Progenitor Cell (PBPC) Mobilization by Filgrastim in Normal DonorsCompletedNCT00115128
- Trial Comparing Pegfilgrastim With Filgrastim as an Adjunct to Chemotherapy for Acute Myeloid Leukaemia (AML)CompletedNCT00114764Phase 2
- Cinacalcet Study to Reach Kidney Disease Outcomes Quality Initiative (K/DOQI) LevelsCompletedNCT00113958Phase 2
- Research Study Evaluating Cinacalcet for Patients With End Stage Renal Disease (ESRD)CompletedNCT00113945Phase 2
- Evaluating Pegfilgrastim and a Multi-Day Topotecan Regimen in Subjects With Relapsed or Refractory Ovarian CancerCompletedNCT00113789Phase 2
- Evaluating ABX-EGF Extended Therapy in Subjects With MetastaticColorectal CancerCompletedNCT00113776Phase 2
- Study for Subjects With Chronic Kidney Disease(CKD) Not Receiving DialysisCompletedNCT00112008Phase 3
- Evaluating Aranesp® for the Treatment of Anemia in African-American Subjects With Chronic Renal Failure (CRF) Receiving HemodialysisCompletedNCT00111995Phase 4
- Trial of Extended Treatment With Liatermin (r-metHuGDNF) Administered by Continuous Intraputaminal (IPu)Infusion to Subjects With Idiopathic Parkinson's Disease Who Have Completed a Previous Trial of LiaterminCompletedNCT00111982Phase 1/2
- Evaluating ABX-EGF in Patients With Metastatic ColorectalCarcinomaCompletedNCT00111774Phase 2
- Evaluating Treatment of Anemia in Subjects With Non-Myeloid MalignanciesReceiving Multicycle ChemotherapyCompletedNCT00111462Phase 2
- Evaluating the Safety of Etanercept 50 mg Twice Weekly in Subjects With PsoriasisCompletedNCT00111449Phase 3
- Evaluating the Safety of Etanercept in the Treatment of Psoriasis in Adult SubjectsCompletedNCT00111436Phase 3
- Evaluating the Safety of Extended Treatment With Pegsunercept (PEG sTNF-RI)in Subjects With Rheumatoid Arthritis (RA)CompletedNCT00111423Phase 2
- Evaluating the Effect of Anakinra (r-metHuIL-1ra) on Vaccine AntibodyResponse in Subjects With Rheumatoid Arthritis (RA)CompletedNCT00111410Phase 4
- Treatment for Patients With Non-Myeloid Malignancies Receiving ChemotherapyCompletedNCT00111137Phase 3
- Enbrel® in Psoriatic ArthritisCompletedNCT00111124Phase 4
- An Evaluation of Etanercept in the Treatment of Subjects With PsoriasisCompletedNCT00111111Phase 3
- Treatment for Subjects With Chronic Kidney Disease (CKD) Not Receiving DialysisCompletedNCT00111098Phase 3
- Utilization of Narrow Band Ultraviolet B (UVB) Light Therapy and Etanercept for the Treatment of PsoriasisCompletedNCT00110981Phase 4
- Treatment of Anemia in Subjects With Non-Myeloid Malignancy Receiving Multicycle ChemotherapyCompletedNCT00110955Phase 3
- Treatment for Patients With Osteoarthritis (OA)CompletedNCT00110942Phase 2
- Treatment for Patients With Secondary Hyperparathyroidism of End-Stage Renal Disease (ESRD)CompletedNCT00110929Phase 2
- Treatment for Patients With Osteoarthritis (OA) of the KneeCompletedNCT00110916Phase 2
- Treatment for Subjects With Active Rheumatoid Arthritis (RA)CompletedNCT00110903Phase 3
- Study To Evaluate the Status of Subjects That Discontinued Participation in a Qualifying Amgen Sponsored AMG 073 Study Due to Kidney TransplantationCompletedNCT00110656
- Safety and Activity Study of an Oral Medication to Treat Moderate to Severe Crohn's DiseaseCompletedNCT00102921Phase 2
- Study Evaluating AMG 386 in Adult Patients With Advanced Solid TumorsCompletedNCT00102830Phase 1
- AMG 531 Treatment of Thrombocytopenic Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) Prior to SplenectomyCompletedNCT00102336Phase 3
- AMG 531 Treatment of Thrombocytopenic Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) Refractory to SplenectomyCompletedNCT00102323Phase 3
- ABX-EGF as Second Line Treatment of Advanced Non-Small-Cell Lung Cancer (NSCLC)CompletedNCT00101920Phase 2
- Safety of AMG 706 Plus Panitumumab Plus Chemotherapy in the Treatment of Subjects With Metastatic Colorectal CancerCompletedNCT00101894Phase 1
- Effectiveness and Safety of Enbrel® (Etanercept) in Rheumatoid Arthritis Subjects Who Have Failed Remicade® (Infliximab)CompletedNCT00099554Phase 4
- Study Evaluating Darbepoetin Alfa in Subjects With Chronic Kidney Disease (CKD) Receiving DialysisCompletedNCT00096915Phase 3
- Darbepoetin Alfa Administered Once Every 4 Weeks in the Treatment of Subjects With Anemia of CancerCompletedNCT00095277Phase 2
- A Study of Darbepoetin Alfa in Anemic Subjects With Low Risk Myelodysplastic SyndromeCompletedNCT00095264Phase 2
- Pegfilgrastim Given Same Day As or Day After Carboplatin and Docetaxel in Advanced Metastatic Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00094822
- Cinacalcet HCl in Chronic Kidney Disease Subjects With Secondary Hyperparathyroidism Not Receiving DialysisCompletedNCT00094484Phase 3
- Preference of Rheumatoid Arthritis (RA) Patients of Enbrel® (Etanercept) Auto-Injector Versus Enbrel® Pre-Filled SyringesCompletedNCT00094341Phase 4
- Study to Assess Darbepoetin Alfa in Subjects With Chronic Kidney DiseaseCompletedNCT00093977Phase 3
- Study Evaluating AMG 706 in Subjects With Advanced Solid TumorsCompletedNCT00093873Phase 1
- Study of Darbepoetin Alfa for the Treatment of Anemia of CancerCompletedNCT00091858Phase 3
- Two Dose Schedules of Panitumumab in Subjects With Advanced Solid TumorsCompletedNCT00091806Phase 1
- Study of AMG 706 in Subjects With Advanced Gastrointestinal Stromal Tumors (GISTs)CompletedNCT00089960Phase 2
- Subcutaneous (SC) Darbepoetin Alfa in Subjects With Symptomatic Congestive Heart Failure (CHF) & AnemiaCompletedNCT00086086Phase 2
- Registry of Etanercept (Enbrel®) In Children With Juvenile Rheumatoid ArthritisCompletedNCT00078793
- Pegfilgrastim PBPC Mobilization StudyCompletedNCT00066092Phase 2
- ABX-EGF (a Monoclonal Antibody) Given to Patients With Prostate Cancer With or Without Tumor in Other Parts of the BodyCompletedNCT00061126Phase 2
- T138067 Versus Doxorubicin in Chemotherapy-Naive, Unresectable, Hepatocellular Carcinoma PatientsTerminatedNCT00057382Phase 2/3
- Heart Failure and AnemiaCompletedNCT00049985Phase 2
- Study of T900607-Sodium in Subjects With Previously Treated Gastric Cancer or Adenocarcinoma of the EsophagusSuspendedNCT00048529Phase 2
- Monoclonal Antibody Treatment for Non-Hodgkin's Lymphoma (Low-Grade)CompletedNCT00044902Phase 2
- Study of T900607-Sodium in Previously Treated Patients With Non-Hodgkin's Lymphoma.TerminatedNCT00043459Phase 2
- Study of T900607-Sodium in Previously Treated Patients With Ovarian Cancer.Status unknownNCT00043446Phase 2
- Study of T900607-Sodium in Chemotherapy Naive Patients With Hepatocellular Carcinoma.Status unknownNCT00043433Phase 2
- A Study of an Investigational Medication for the Treatment of Secondary Hyperparathyroidism in Patients on DialysisCompletedNCT00042653Phase 3
- Recombinant Human Keratinocyte Growth Factor to Reduce Oral Mucositis in Hematologic Malignancy Patients Undergoing Peripheral Blood Stem Cell Transplantation After Radiation and High-dose ChemotherapyCompletedNCT00041665Phase 3
- A Rheumatoid Arthritis (RA) Study Treating Signs and Symptoms of RA in People With RA & Receiving MethotrexateCompletedNCT00038298Phase 2
- Anemia in Patients With a Non-Myeloid MalignancyCompletedNCT00038064Phase 3
- Evaluation of the Efficacy of Combination Treatment With Anakinra and Pegsunercept in Improving Rheumatoid ArthritisCompletedNCT00037700Phase 2
- Juvenile Rheumatoid ArthritisCompletedNCT00037648Phase 2
- A Study of an Investigational Medication for the Treatment of Secondary Hyperparathyroidism in Dialysis PatientsCompletedNCT00037635Phase 3
- A Study of an Investigational Medication for Severe Primary Hyperparathyroidism or Parathyroid CancerCompletedNCT00037518Phase 4
- Chemotherapy Related Anemia in Patients With Non-Myeloid MalignanciesCompletedNCT00036023Phase 2
- Study Comparing ABX-CBL (Monoclonal Antibody) Versus Atgam in Patients With Steroid Resistant Acute Graft Versus Host DiseaseCompletedNCT00035880Phase 2/3
- A Blinded Study Comparing the Safety and Efficacy of a Fully Human Anti-IL8 Monoclonal Antibody (ABX-IL8) to Placebo in Patients With Chronic Bronchitis and COPDCompletedNCT00035828Phase 2
- Pegfilgrastim as Support to Pediatric Sarcoma Patients Receiving ChemotherapyCompletedNCT00035620Phase 2
- Chemotherapy Related AnemiaCompletedNCT00035607Phase 2
- Pegfilgrastim as Support to Advanced Breast Cancer Patients Receiving ChemotherapyCompletedNCT00035594Phase 3
- ABX-EGF in Combination With Paclitaxel and Carboplatin for the Treatment of Advanced Non-Small-Cell Lung Cancer (NSCLC)CompletedNCT00034346Phase 2
- Lometrexol Plus Folic Acid in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerStatus unknownNCT00033722Phase 2
- T138067 in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer That Has Not Responded to Previous ChemotherapyStatus unknownNCT00022243Phase 2
- Docetaxel and Vinorelbine Plus Filgrastim in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerStatus unknownNCT00006215Phase 2
- Combination Chemotherapy in Treating Patients With Prostate Cancer That Has Not Responded to Hormone TherapyStatus unknownNCT00005960Phase 2
- Combination Chemotherapy Plus Rituximab in Treating Patients With Intermediate-Grade or High-Grade Non-Hodgkin's LymphomaStatus unknownNCT00005959Phase 2
- Combination Chemotherapy Plus Filgrastim in Treating Patients With Locally Recurrent or Advanced Urothelium CancerStatus unknownNCT00005958Phase 2
- The Effects of r-metHuIFN-Gamma on the Lungs of Patients With AIDSCompletedNCT00002433Not applicable
- A Study of Granulocyte Colony-Stimulating Factor Plus Recombinant Erythropoietin Plus Zidovudine in Patients With AIDS or AIDS-Related ComplexCompletedNCT00002281Not applicable
- An Open-Label Phase I/II Study of Recombinant Granulocyte Colony Stimulating Factor (r-metHuG-CSF) and Recombinant Erythropoietin (rHuEPO) Given Subcutaneously Along With Zidovudine (AZT) to Patients With the Acquired Immune Deficiency Syndrome (AIDS) or Severe AIDS-Related Complex (ARC)CompletedNCT00002255Phase 1
- A Randomized, Controlled, Multicenter Trial of Filgrastim (Recombinant-Methionyl Human Granulocyte Colony Stimulating Factor; G-CSF) for the Prevention of Grade 4 Neutropenia in Patients With HIV Infection.CompletedNCT00002126Phase 2
- Evaluation of the Therapeutic Benefit of r-metHuIFN- Gamma in AIDS Patients With Disseminated Mycobacterium Avium-Intracellulare (MAI) Infection: A Multi-Centered Pilot StudyCompletedNCT00002037Not applicable